SQUABB-6V4

Indication are limited to infections caused by bacteria known to be sensitive to this antibiotics.
Therapeutic use :

  • Documented streptococcal tonsillitis caused by Group A beta-hemolytic streptococcus
  • Mild skin infections caused by sensitive organisms

Prophylactic use :

  • Prevention of recurrent rheumatic fever (RRF)
  • Prevention of recurrent erysipelas
  • In close contracts of individuals with scarlet fever
  • Pneumococcal infection prevention in idividuals who are :
  • Splenectomized
  • Sickle cell patients
  • Other functionally asplenic individuals

SQUABB-6V4

COMPOSITIONS :
Each tablet contains :

  • Phenoxymethylpenicillin…………………………………….. 400,000 IU
  • Excipients : q.s. ……………………………………………………..one tablet

THERAPEUTIC PROPERTIES
This is an antibiotic from the beta-lactam family, specifically from the natural penicillins group, of the phenoxymethylpenicillin type.
INDICATIONS
Indication are limited to infections caused by bacteria known to be sensitive to this antibiotics.
Therapeutic use :

  • Documented streptococcal tonsillitis caused by Group A beta-hemolytic streptococcus
  • Mild skin infections caused by sensitive organisms

Prophylactic use :

  • Prevention of recurrent rheumatic fever (RRF)
  • Prevention of recurrent erysipelas
  • In close contracts of individuals with scarlet fever
  • Pneumococcal infection prevention in idividuals who are :
  • Splenectomized
  • Sickle cell patients
  • Other functionally asplenic individuals
CONTREAINDICATIONS
  • Allergy to beta-lactam antibiotics (Penicillins and cephalosporins)
  • Concomitant use of methotrexate
IN CASE OF DOUBT, IT IS ESSENTIAL TO CONSULT YOUR DOCTOR OR PHARMACIST .

PRECEUTION

  • The appearance of any allergic reaction required immediate discontinuation of the treatment and initiation of appropriate care.
SIDE EFFECT
–         Allergic reactions : fever, hives, angioedema (Quincke’s edema), and in rare cases, anaphylactic shock
–         Digestive issues : nausea, vomiting, diarrhea, black tongue with prolonged treatment
–         Reversible hematologic reactions : anemia, thrombocytopenia, leukopnia, and conagulation disorders.
DOSAGE AND ADMINISTRATION

Therapeutic Use :
Daily doses should be divided into 2-3 doses for tonsillitis, and 3-4 doses for other indications.

  • Adults : 2,000,000 to 4,000,000 IU/day
  • Infants and children up to 40 kg : 50,000 to 100,000 IU/kg/day
  • Duration : 10 days for tonsillitis

Prophylactic Use :
Daily doses should be divided into two doses.

  • Infants and children :
  • Up to 10kg : 100,000 IU/kg/day
  • From 10kg to 40kg : 50,000 IU/kg/day (not to exceed 2,000,000 IU/day)
  • Adults : 2,000,000 IU/day
  • Duration : Prophylaxis should continue for at least 2 years after splenectomy

 

Reviews

There are no reviews yet.

Be the first to review “SQUABB-6V4”

Your email address will not be published. Required fields are marked *